* Banking stocks outperform
* Ono Pharmaceutical jumps
By Ayai Tomisawa
TOKYO, Dec 27 (Reuters) - Japan's Nikkei share average edged up on Tuesday morning in thin trade while Toshiba Corp plummeted on news that it was considering booking a goodwill impairment loss of several hundreds of billion yen.
The Nikkei .N225 gained 0.2 percent to 19,443.26 in midmorning trade.
Overall sentiment was steady as the dollar was up 0.1 percent at 117.230 yen JPY= after spending the previous day in a narrow 117.005-117.390 range as many major financial markets were closed for Christmas holidays.
"While foreign investors are away for the holidays, retail investors are the main players today," said Hikaru Sato, a senior technical analyst at Daiwa Securities.
Institutional investors are on the sidelines amid a lack of economic catalysts, he added.
Ono Pharmaceutical Co 4528.T soared more than 5 percent after the Nikkei newspaper reported that the company plans to sell its cancer treatment drug, Opdivo, in the domestic market in the next fiscal year to treat stomach cancer.
Toshiba 6502.T tumbled as much as 16 percent after the company said it was considering booking a goodwill impairment loss of several hundreds of billion yen on a U.S. nuclear power acquisition made by its Westinghouse division. broader Topix .TOPX gained 0.2 percent to 1,541.48 and the JPX-Nikkei Index 400 .JPXNK400 advanced 0.3 percent to 13,824.38.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.